What is Moderna's pre-tax income?

Moderna (MRNA) reported pre-tax income of -$1.33B in Q1 2026.

How has Moderna's pre-tax income changed year-over-year?

Moderna's pre-tax income decreased by 38.4% year-over-year, from -$964M to -$1.33B.

What is the long-term trend for Moderna's pre-tax income?

Over 4 years (2021 to 2025), Moderna's pre-tax income has grown at a -32.4% compound annual growth rate (CAGR), from $13.29B to -$2.77B.

What does pre-tax income mean?

Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Moderna MRNA Pre-Tax Income

Pre-Tax Income at other companies

PfizerPFE

$3.17B+13.8%

NovavaxNVAX

-$8.51M-102%

ALN

Alnylam PharmaceuticalsALNY

$177.81M+603%

Ultragenyx PharmaceuticalRARE

-$184M-22.7%

Gilead SciencesGILD

$2.58B+56.5%

Other financials

Income statement

See full

Revenue$389.0M+260%

Gross profit-$566.0M-3,244%

Operating income-$1.4B-32.2%

Net income-$1.3B-38.3%

EPS (diluted)-$3.40-34.9%

Balance sheet

See full

Cash & equivalents$1.9B+17.4%

Total debt$1.3B+71.9%

Total equity$7.4B-26.4%

Total assets$11.5B-9.6%

Cash flow

See full

Operating cash flow-$630.0M+39.2%

CapEx$62.0M-47.0%

Free cash flow-$692.0M+40.0%

Valuation

See full

Market cap$22.14B+75.3%

Enterprise value$21.56B+77.9%

P/S10×+5.8×

Profitability

See full

Gross margin22.1%-32.0pp

Operating margin-153.3%+67.8pp

Net margin-143.6%+80.2pp

FCF margin-132.4%—

Returns & leverage

See full

Return on equity-36.6%+11.9pp

Debt / equity0.2×+0.1×

Current ratio2.4×-1.8×

Where this comes from

Reported directly by Moderna in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The official record: Moderna’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Moderna's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Moderna's pre-tax income?: Moderna (MRNA) reported pre-tax income of -$1.33B in Q1 2026.
How has Moderna's pre-tax income changed year-over-year?: Moderna's pre-tax income decreased by 38.4% year-over-year, from -$964M to -$1.33B.
What is the long-term trend for Moderna's pre-tax income?: Over 4 years (2021 to 2025), Moderna's pre-tax income has grown at a -32.4% compound annual growth rate (CAGR), from $13.29B to -$2.77B.
What does pre-tax income mean?: Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.